| Pharmaceutical active ingredients: |
| Dequalinium Chloride |
| Available forms, composition and doses of Laryngarsol Lozenges: |
| Lozenges; Oral; Dequalinium Chloride |
| Laryngarsol Lozenges medical category: |
| Human:Miscellaneous anti-infectivesMouth / throat preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D08AH01 - DequaliniumG01AC05 - DequaliniumR02AA02 - Dequalinium |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lantus Solostar | Insulin Glargine | Sanofi-Aventis; DKSH; Four Star; IDS Group; Zuellig Pharma |
| Lanzor | Lansoprazole | Sanofi-Aventis |
| Lao-Dal | Camphor; Chloroform; Glycol Salicylate; Lidocaine Hydrochloride; Menthol; Methyl Salicylate; Turpentine Oil | Sanofi-Aventis |
| Largactil | Chlorpromazine Hydrochloride | Sanofi-Aventis; Hawgreen; Teofarma; Vitoria Laboratorios |
| Largatrex | Chlorpromazine; Heptaminol; Trihexyphenidyl | Sanofi-Aventis; Vitoria Laboratorios |
| Lasex | Furosemide | Sanofi-Aventis |
| Lasikal | Furosemide; Potassium Chloride | Sanofi-Aventis; Borg Medicare |
| Lasilacton | Furosemide; Spironolactone | Sanofi-Aventis |
| Lasilactona | Furosemide; Spironolactone | Sanofi-Aventis |
| Lasilactone | Furosemide; Spironolactone | Sanofi-Aventis; Borg Medicare |